ArriVent BioPharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 4.52 M | $156.87 M | 2.60% | 10.02% |
| INFINITUM ASSET MANAGEMENT, LLC | 08/14/2026 | 4.44 M | $154.19 M | 6.98% | 9.85% |
| HHLR ADVISORS, LTD. | 08/14/2026 | 3.93 M | $136.50 M | 0.00% | 8.72% |
| BLACKROCK, INC. | 08/07/2026 | 3.25 M | $112.92 M | 28.46% | 7.21% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 3.03 M | $105.17 M | 0.00% | 6.72% |
| FMR LLC | 08/13/2026 | 2.78 M | $96.54 M | -7.86% | 6.17% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 1.97 M | $68.47 M | 0.00% | 4.37% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.77 M | $61.66 M | 16.09% | 3.94% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 1.70 M | $58.95 M | 0.00% | 3.76% |
| STATE STREET CORP | 08/07/2026 | 1.69 M | $58.81 M | 19.11% | 3.76% |
| VIVO CAPITAL, LLC | 08/14/2026 | 1.68 M | $58.44 M | 89.87% | 3.73% |
| NOVO HOLDINGS A/S | 08/14/2026 | 1.50 M | $52.11 M | -22.77% | 3.33% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 08/17/2026 | 1.49 M | $51.93 M | 0.00% | 3.32% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 1.00 M | $34.74 M | 185.71% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 972.63 K | $33.80 M | 21.03% | 2.16% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 872.01 K | $30.29 M | 136.45% | 1.93% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 853.72 K | $29.66 M | 0.03% | 1.89% |
| SC CHINA HOLDING LTD | 08/13/2026 | 663.31 K | $23.04 M | 0.00% | 1.47% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 566.80 K | $19.69 M | -24.24% | 1.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 508.30 K | $17.66 M | 288.02% | 1.13% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 438.66 K | $15.24 M | 2.99% | 0.97% |
| UBS GROUP AG | 08/13/2026 | 438.59 K | $15.24 M | -9.80% | 0.97% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 395.45 K | $13.74 M | -7.23% | 0.88% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 381.59 K | $13.26 M | 111.96% | 0.85% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 335.32 K | $11.65 M | 32.09% | 0.74% |
| NORTHERN TRUST CORP | 08/13/2026 | 332.75 K | $11.56 M | 23.79% | 0.74% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/14/2026 | 301.34 K | $10.47 M | 100.00% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 294.22 K | $10.22 M | 13.70% | 0.65% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 294.22 K | $10.22 M | 100.00% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 259.29 K | $9.01 M | 19.42% | 0.58% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 246.61 K | $8.57 M | 390.74% | 0.55% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2026 | 218.69 K | $7.60 M | 100.00% | 0.49% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 211.51 K | $7.35 M | 67.17% | 0.47% |
| MORGAN STANLEY | 08/13/2026 | 189.91 K | $6.60 M | 47.74% | 0.42% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 183.00 K | $6.36 M | 100.00% | 0.41% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 174.87 K | $6.07 M | 118.02% | 0.39% |
| CITADEL ADVISORS LLC | 08/14/2026 | 156.74 K | $5.45 M | -5.67% | 0.35% |
| NOMURA HOLDINGS INC | 08/14/2026 | 154.62 K | $5.37 M | -36.12% | 0.34% |
| WOODLINE PARTNERS LP | 08/14/2026 | 147.64 K | $5.13 M | 0.00% | 0.33% |
| JANE STREET GROUP, LLC | 08/14/2026 | 138.50 K | $4.81 M | 150.00% | 0.31% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 125.00 K | $4.34 M | -28.57% | 0.28% |
| HRT FINANCIAL LP | 08/14/2026 | 121.22 K | $4.21 M | 157.63% | 0.27% |
| E FUND MANAGEMENT CO., LTD. | 08/11/2026 | 109.33 K | $3.80 M | 16.36% | 0.24% |
| NUVEEN, LLC | 08/11/2026 | 107.85 K | $3.75 M | 89.75% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 103.93 K | $3.61 M | 37.75% | 0.23% |
| KVP CAPITAL ADVISORS, LP | 08/13/2026 | 102.00 K | $3.54 M | 100.00% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 100.86 K | $3.50 M | 28.95% | 0.22% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 100.00 K | $3.47 M | 0.00% | 0.22% |
| CITADEL ADVISORS LLC | 08/14/2026 | 81.60 K | $2.83 M | -49.41% | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 08/14/2026 | 79.04 K | $2.75 M | 163.36% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma Inc. institutional Ownership - FAQ's
During the previous two years, 184 institutional investors and hedge funds held shares of ArriVent BioPharma Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.52 M
INFINITUM ASSET MANAGEMENT, LLC: 4.44 M
HHLR ADVISORS, LTD.: 3.93 M
BlackRock, Inc.: 3.25 M
ORBIMED ADVISORS LLC: 3.03 M
FMR LLC: 2.78 M
102.92% of ArriVent BioPharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.61 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.